Hyderabad Telangana, India

Thrisulapani Korrakuti

This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignee: Taxis Pharmaceuticals, Inc.. Active years: 2019-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thrisulapani Korrakuti. Retrieved from https://idiyas.com/inventor/thrisulapani-korrakuti

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 8.2

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2019-2024

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Thrisulapani Korrakuti

Introduction

Thrisulapani Korrakuti is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of synthetic processes and intermediates.

Latest Patents

Korrakuti holds three patents, with his latest inventions focusing on synthetic processes and synthetic intermediates. These inventions are particularly useful for preparing the antibacterial agent TXA709. His work in this area demonstrates his commitment to advancing pharmaceutical science and improving healthcare outcomes.

Career Highlights

Thrisulapani Korrakuti is currently associated with Taxis Pharmaceuticals, Inc., where he continues to innovate and contribute to the field. His expertise in synthetic chemistry has positioned him as a valuable asset in the pharmaceutical industry.

Collaborations

Korrakuti has collaborated with several professionals in his field, including Ravi Ponnaiah and Anil Kumar Soni. These collaborations have further enhanced his research and development efforts.

Conclusion

Thrisulapani Korrakuti's work in synthetic processes and his contributions to the pharmaceutical industry highlight his role as an influential inventor. His patents and collaborations reflect his dedication to advancing medical science and improving public health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…